SAN DIEGO, May 12 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc. (PICR) today announced that president and CEO Dr. Marcus Hompesch is a finalist for the Ernst & Young Entrepreneur Of The Year® 2010 Award in San Diego for the second year in a row. Award winners will be announced at a gala event on June 9, 2010 at the Hyatt La Jolla Aventine.
Dr. Hompesch is being recognized for his establishment and leadership of PICR, headquartered in Chula Vista, Calif. PICR has emerged as an industry leader in performing phase I and II clinical trials for pharmaceutical companies by honing their clinical expertise and specifically focusing on new treatments for diabetes and obesity.
Under Dr. Hompesch's leadership, the team at PICR has conducted more than 120 clinical studies investigating new drugs and devices since the company began operations in 2004 and has been involved with almost every clinically promising drug and device development in the diabetes arena.
"I am honored to have been selected as a finalist for this prestigious award for a second year in a row," said Dr. Hompesch. "It is not only personally rewarding to be recognized with these highly respected entrepreneurs, but is, in fact, a wonderful testament to what our team at PICR has been able to accomplish."
Dr. Hompesch is one of three finalists in the Health Sciences category for the San Diego regional awards ceremony. The other finalists in this category are Jonathan Lim, President and CEO of Halozyme Therapeutics, and Scott Huennekens,
|SOURCE Profil Institute for Clinical Research, Inc.|
Copyright©2010 PR Newswire.
All rights reserved